Intersect ENT Inc (NASDAQ:XENT)

26.74
Delayed Data
As of 9:45am ET
 +0.33 / +1.25%
Today’s Change
12.02
Today|||52-Week Range
27.21
+44.15%
Year-to-Date
No recent news for Intersect ENT Inc.

Today’s Trading

Previous close26.41
Today’s open26.57
Day’s range25.00 - 27.21
Volume27,632
Average volume (3 months)114,124
Market cap$617.4M
Dividend yield--
Data as of 9:45am ET, 03/02/2015

Growth & Valuation

Earnings growth (last year)-26.09%
Earnings growth (this year)--
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+205.83%
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
INGNInogen Inc+0.08+0.25%
BLCMBellicum Pharmaceuti...-0.08-0.34%
ATRIAtrion Corp0.000.00%
ANIKAnika Therapeutics I...+0.75+1.88%
Data as of 10:00am ET, 03/02/2015

Financials

Next reporting dateJune 3, 2015
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$17.9M
Annual profit (last year)-$18.4M
Net profit margin-102.44%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Lisa D. Earnhardt
COO, Senior VP-Research &
Development
Richard E. Kaufman
Corporate headquarters
Menlo Park, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account